Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Natural Health Trends (NHTC) over the last 16 years, with Q3 2025 value amounting to $1.0 million.

  • Natural Health Trends' Accounts Payables rose 8448.91% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 8448.91%. This contributed to the annual value of $895000.0 for FY2024, which is 959.6% down from last year.
  • Latest data reveals that Natural Health Trends reported Accounts Payables of $1.0 million as of Q3 2025, which was up 8448.91% from $962000.0 recorded in Q2 2025.
  • Natural Health Trends' Accounts Payables' 5-year high stood at $1.1 million during Q1 2023, with a 5-year trough of $548000.0 in Q3 2024.
  • Moreover, its 5-year median value for Accounts Payables was $824000.0 (2022), whereas its average is $848000.0.
  • In the last 5 years, Natural Health Trends' Accounts Payables tumbled by 3469.92% in 2024 and then surged by 8448.91% in 2025.
  • Quarter analysis of 5 years shows Natural Health Trends' Accounts Payables stood at $761000.0 in 2021, then increased by 6.44% to $810000.0 in 2022, then rose by 22.22% to $990000.0 in 2023, then fell by 9.6% to $895000.0 in 2024, then increased by 12.96% to $1.0 million in 2025.
  • Its Accounts Payables stands at $1.0 million for Q3 2025, versus $962000.0 for Q2 2025 and $968000.0 for Q1 2025.